Dashboard
Manage Tickers

LEGN


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

rbc-capital-maintains-outperform-on-legend-biotech-lowers-price-target-to-74
RBC Capital Maintains Outperform on Legend...
11/13/2025 17:36:44

RBC Capital analyst Leonid Timashev maintains Legend Biotech (NASDAQ:LEGN) with a Outperform and lowers the price target fro...

legend-biotech-announces-official-opening-of-its-new-rd-facility-in-philadelphia
Legend Biotech Announces Official Opening ...
11/13/2025 17:14:50

31,000-square-foot site expands Legend's U.S. R&D footprint and strengthens its position as a global leader in cell the...

cantor-fitzgerald-maintains-overweight-on-legend-biotech-raises-price-target-to-75
Cantor Fitzgerald Maintains Overweight on ...
11/13/2025 14:08:40

Cantor Fitzgerald analyst Eric Schmidt maintains Legend Biotech (NASDAQ:LEGN) with a Overweight and raises the price target ...

legend-biotech-q3-adj-eps-005-beats-010-estimate-sales-272330m-miss-272499m-estimate
Legend Biotech Q3 Adj. EPS $(0.05) Beats $...
11/12/2025 12:00:54

Legend Biotech (NASDAQ:LEGN) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.10...

earnings-scheduled-for-november-12-2025
Earnings Scheduled For November 12, 2025
11/12/2025 11:11:28

what-to-expect-from-legend-biotechs-earnings
What to Expect from Legend Biotech's Earnings
11/11/2025 14:03:02

amd-to-rally-around-28-here-are-10-top-analyst-forecasts-for-friday
AMD To Rally Around 28%? Here Are 10 Top A...
10/17/2025 11:46:48

hc-wainwright--co-maintains-buy-on-legend-biotech-lowers-price-target-to-60
HC Wainwright & Co. Maintains Buy on Legen...
10/17/2025 10:43:46

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Legend Biotech (NASDAQ:LEGN) with a Buy and lowers the price ta...

expert-outlook-legend-biotech-through-the-eyes-of-6-analysts
Expert Outlook: Legend Biotech Through The...
10/09/2025 18:00:45

jp-morgan-maintains-overweight-on-legend-biotech-lowers-price-target-to-76
JP Morgan Maintains Overweight on Legend B...
10/09/2025 13:45:59

JP Morgan analyst Jessica Fye maintains Legend Biotech (NASDAQ:LEGN) with a Overweight and lowers the price target from $78 ...

Core News & Articles
Legend Biotech Says Legend Biotech USA Ent...
10/07/2025 20:15:04

Legend Biotech USA Inc. Enters into Component and Product Supply Agreement with Janssen Pharmaceuticals, Inc.On October 6, 2025...

how-do-investors-really-feel-about-legend-biotech
How Do Investors Really Feel About Legend ...
09/22/2025 16:00:47

legend-biotech-is-said-to-explore-second-listing-outside-of-us--bloomberg
'Legend Biotech Is Said to Explore Second ...
09/05/2025 14:48:14

https://www.bloomberg.com/news/articles/2025-09-05/legend-biotech-is-said-to-explore-second-listing-outside-of-us

how-do-investors-really-feel-about-legend-biotech
How Do Investors Really Feel About Legend ...
09/04/2025 17:00:27

cantor-fitzgerald-assumes-legend-biotech-at-overweight-announces-price-target-of-66
Cantor Fitzgerald Assumes Legend Biotech a...
08/27/2025 13:03:46

Cantor Fitzgerald analyst Eric Schmidt assumes Legend Biotech (NASDAQ:LEGN) with a Overweight rating and announces Price Tar...

jp-morgan-maintains-overweight-on-legend-biotech-raises-price-target-to-78
JP Morgan Maintains Overweight on Legend B...
08/25/2025 14:07:54

JP Morgan analyst Jessica Fye maintains Legend Biotech (NASDAQ:LEGN) with a Overweight and raises the price target from $77 ...

legend-biotech-appoints-carlos-santos-as-cfo
Legend Biotech Appoints Carlos Santos As CFO
08/18/2025 12:01:55

rbc-capital-maintains-outperform-on-legend-biotech-raises-price-target-to-77
RBC Capital Maintains Outperform on Legend...
08/12/2025 14:04:40

RBC Capital analyst Leonid Timashev maintains Legend Biotech (NASDAQ:LEGN) with a Outperform and raises the price target fro...

the-analyst-verdict-legend-biotech-in-the-eyes-of-5-experts
The Analyst Verdict: Legend Biotech In The...
08/12/2025 13:00:39

morgan-stanley-maintains-overweight-on-legend-biotech-raises-price-target-to-83
Morgan Stanley Maintains Overweight on Leg...
08/12/2025 12:28:05

Morgan Stanley analyst Matthew Harrison maintains Legend Biotech (NASDAQ:LEGN) with a Overweight and raises the price target...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION